225 related articles for article (PubMed ID: 29626738)
1. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
[TBL] [Abstract][Full Text] [Related]
3. Return on Investment of a Breast Cancer Screening Program in Tanzania: Opportunity for Patient and Public Education.
Heisler Z; Eastwood B; Mwaiselage J; Kahesa C; Msami K; Soliman AS
J Cancer Educ; 2022 Jun; 37(3):701-708. PubMed ID: 32980979
[TBL] [Abstract][Full Text] [Related]
4. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
5. Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.
Salikhanov I; Crape B; Howie P
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3153-3160. PubMed ID: 31653167
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Population Screening Program Results in Early Detection and Reduced Treatment and Health Care Costs for Medicaid.
Homan SG; Yun S; Bouras A; Schmaltz C; Gwanfogbe P; Lucht J
J Public Health Manag Pract; 2021; 27(1):70-79. PubMed ID: 31592983
[TBL] [Abstract][Full Text] [Related]
7. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
Moger TA; Bjørnelv GM; Aas E
Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China].
Mo M; Zheng Y; Liu G; Fang H; Zhang X; Zhai L; Chen Y; Lyu L; Zhu J; Luo J; Zhang L; Cao Z; Xu W; Shao Z
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):944-51. PubMed ID: 26887627
[TBL] [Abstract][Full Text] [Related]
9. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
10. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
11. Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Subramanian S; Trogdon JG; Miller JW; Royalty JE; Li C; Guy GP; Crouse W; Thompson H; Gardner JG
Cancer; 2014 Aug; 120 Suppl 16(Suppl 16):2604-11. PubMed ID: 25099904
[TBL] [Abstract][Full Text] [Related]
12. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
[TBL] [Abstract][Full Text] [Related]
13. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.
Denewer A; Hussein O; Farouk O; Elnahas W; Khater A; El-Saed A
World J Surg; 2010 Sep; 34(9):2204-10. PubMed ID: 20533039
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
Allaire BT; Ekweme D; Hoerger TJ; DeGroff A; Rim SH; Subramanian S; Miller JW
Cancer Causes Control; 2019 Sep; 30(9):923-929. PubMed ID: 31297693
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
18. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
19. Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer.
Kauhava L; Immonen-Räihä P; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Breast Cancer Res Treat; 2006 Jul; 98(2):143-50. PubMed ID: 16538536
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
